These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36694268)

  • 61. Nitration of amyloid-β peptide (1-42) as a protective mechanism for the amyloid-β peptide (1-42) against copper ion toxicity.
    Zhao J; Gao W; Yang Z; Li H; Gao Z
    J Inorg Biochem; 2019 Jan; 190():15-23. PubMed ID: 30342351
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A new method to measure cellular toxicity of non-fibrillar and fibrillar Alzheimer's Abeta using yeast.
    Bharadwaj P; Waddington L; Varghese J; Macreadie IG
    J Alzheimers Dis; 2008 Mar; 13(2):147-50. PubMed ID: 18376056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. De novo aggregation of Alzheimer's Aβ25-35 peptides in a lipid bilayer.
    Smith AK; Klimov DK
    Sci Rep; 2019 May; 9(1):7161. PubMed ID: 31073226
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interplay of isoform 1N4R tau protein and amyloid-β peptide fragment 25-35 in reducing and non-reducing conditions.
    Mohammadi F; Takalloo Z; Rahmani H; Nasiri Khalili MA; Khajeh K; Riazi G; H Sajedi R
    J Biochem; 2021 Feb; 169(1):119-134. PubMed ID: 32857841
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis.
    Soto C; Castaño EM
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):701-7. PubMed ID: 8670088
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DHPC strongly affects the structure and oligomerization propensity of Alzheimer's Aβ(1-40) peptide.
    Dahse K; Garvey M; Kovermann M; Vogel A; Balbach J; Fändrich M; Fahr A
    J Mol Biol; 2010 Nov; 403(4):643-59. PubMed ID: 20851128
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.
    Naldi M; Fiori J; Pistolozzi M; Drake AF; Bertucci C; Wu R; Mlynarczyk K; Filipek S; De Simone A; Andrisano V
    ACS Chem Neurosci; 2012 Nov; 3(11):952-62. PubMed ID: 23173074
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Curcumin Binding to Beta Amyloid: A Computational Study.
    Rao PP; Mohamed T; Teckwani K; Tin G
    Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interactions between gold nanoparticles and amyloid β25-35 peptide.
    Peng J; Weng J; Ren L; Sun LP
    IET Nanobiotechnol; 2014 Dec; 8(4):295-303. PubMed ID: 25429511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP).
    Williams TL; Serpell LC; Urbanc B
    Biochim Biophys Acta; 2016 Mar; 1864(3):249-259. PubMed ID: 26699836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue.
    Ghosh U; Thurber KR; Yau WM; Tycko R
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33431654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhancing the binding of the β-sheet breaker peptide LPFFD to the amyloid-β fibrils by aromatic modifications: A molecular dynamics simulation study.
    Kanchi PK; Dasmahapatra AK
    Comput Biol Chem; 2021 Jun; 92():107471. PubMed ID: 33706107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
    Soto C; Kindy MS; Baumann M; Frangione B
    Biochem Biophys Res Commun; 1996 Sep; 226(3):672-80. PubMed ID: 8831674
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lanosterol Disrupts the Aggregation of Amyloid-β Peptides.
    Zhou H; Yang Z; Tian X; Chen L; Lee S; Huynh T; Ge C; Zhou R
    ACS Chem Neurosci; 2019 Sep; 10(9):4051-4060. PubMed ID: 31369236
    [TBL] [Abstract][Full Text] [Related]  

  • 75. X-ray diffraction and far-UV CD studies of filaments formed by a leucine-rich repeat peptide: structural similarity to the amyloid fibrils of prions and Alzheimer's disease beta-protein.
    Symmons MF; Buchanan SG; Clarke DT; Jones G; Gay NJ
    FEBS Lett; 1997 Jul; 412(2):397-403. PubMed ID: 9256259
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.
    Connelly L; Jang H; Arce FT; Capone R; Kotler SA; Ramachandran S; Kagan BL; Nussinov R; Lal R
    J Phys Chem B; 2012 Feb; 116(5):1728-35. PubMed ID: 22217000
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Copper enhances amyloid-beta peptide neurotoxicity and non beta-aggregation: a series of experiments conducted upon copper-bound and copper-free amyloid-beta peptide.
    Dai X; Sun Y; Gao Z; Jiang Z
    J Mol Neurosci; 2010 May; 41(1):66-73. PubMed ID: 19685013
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation.
    White AR; Maher F; Brazier MW; Jobling MF; Thyer J; Stewart LR; Thompson A; Gibson R; Masters CL; Multhaup G; Beyreuther K; Barrow CJ; Collins SJ; Cappai R
    Brain Res; 2003 Mar; 966(2):231-44. PubMed ID: 12618346
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
    Cottingham MG; Hollinshead MS; Vaux DJ
    Biochemistry; 2002 Nov; 41(46):13539-47. PubMed ID: 12427014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.